Chemomab Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 08/14/2025 | 940.99 K | $1.09 M | -45.96% | 0.21% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2025 | 738.05 K | $856.14 K | -18.03% | 0.16% |
| YELIN LAPIDOT HOLDINGS MANAGEMENT LTD. | 08/06/2025 | 578.29 K | $670.82 K | 0.00% | 0.13% |
| IKARIAN CAPITAL, LLC | 08/14/2025 | 213.05 K | $247.14 K | 0.00% | 0.05% |
| RHUMBLINE ADVISERS | 08/12/2025 | 39.88 K | $46.25 K | 67.20% | 0.01% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 08/07/2025 | 31.24 K | $36.24 K | 0.00% | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2025 | 26.19 K | $30.38 K | 0.00% | 0.01% |
| JANE STREET GROUP, LLC | 08/14/2025 | 20.57 K | $23.86 K | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/14/2025 | 13.90 K | $16.12 K | 32.38% | 0.00% |
| GAMMA INVESTING LLC | 07/14/2025 | 12.81 K | $14.86 K | 16.17% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2025 | 1.18 K | $1.37 K | 100.00% | 0.00% |
| UBS GROUP AG | 08/14/2025 | 397 | $461 | -55.04% | 0.00% |
| SBI SECURITIES CO., LTD. | 08/08/2025 | 111 | $129 | 6.73% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| MOSER WEALTH ADVISORS, LLC | 07/31/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| WETZEL INVESTMENT ADVISORS, INC. | 07/18/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Chemomab Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 17 institutional investors and hedge funds held shares of Chemomab Therapeutics Ltd.. The most heavily invested institutionals were:
Yelin Lapidot Holdings Management Ltd.: 0
BNP PARIBAS ARBITRAGE, SNC: 0
RHUMBLINE ADVISERS: 0
GAMMA Investing LLC: 0
UBS Group AG: 0
SBI Securities Co., Ltd.: 0
0.57% of Chemomab Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 28.85 K shares in the last 24 months. This purchase volume represents approximately $78.47 K in transactions.